Clinical trial

Phase 2 Study of Ambrisentan for Liver Function Test Rescue in Pulmonary Arterial Hypertension

NCT00423592

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-05-01

PhasePHASE2

Study timeline

Study start (unknown)2005-05-01Date precision: month

Registry last updated2013-06-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Hypertensionunresolved

Interventions

ambrisentanDRUG · verified · RxNorm: ambrisentan

Sponsors & collaborators

Gilead Scienceslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00423592 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.